Author

Mila van der Borgh

University of Arizona

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Coen A. C. OttenheijmiD· 1 shared Esmat Karimi· 1 shared Henk L. M. GranzieriD· 1 shared Jochen GohlkeiD· 1 shared Johan LindqvistiD· 1 shared Justin S. KolbiD· 1 shared Michael William LawloriD· 1 shared Stacy A. CossetteiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Coen A. C. OttenheijmORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Characterization of NEB mutations in patients reveals novel nemaline myopathy disease mechanisms and omecamtiv mecarbil force effects

Esmat Karimi, Mila van der Borgh, Johan Lindqvist, Jochen Gohlke, Zaynab Hourani, Justin S. Kolb, Stacy A. Cossette, Michael William Lawlor, Coen A. C. Ottenheijm, Henk L. M. Granzier

This study characterizes NEB mutations in NEM2 patients, revealing mechanisms of nebulin dysfunction and the potential therapeutic benefit of Omecamtiv mecarbil.

bioRxiv · Dec 20, 2023 · PreprintGenetics